Organon & Co. (OGN): $33.17

-0.55 (-1.63%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Organon & Co (OGN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering OGN.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $48 $35 $41.8 $33.42 25.07%

The Trend in the Analyst Price Target


OGN's average price target has moved up $3.6 over the prior 41 days.

Over the past 90 days, OGN's average upside potential has been 25.67%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-11 5 48 35 41.80 33.88 23.38%
2021-09-04 6 48 33 40.33 35.61 13.25%
2021-08-28 5 48 33 39.80 34.25 16.2%
2021-08-14 5 48 33 37.80 34.21 10.49%
2021-08-07 5 48 33 38.20 29.50 29.49%
2021-08-05 5 48 33 38.20 29.56 29.23%
2021-08-01 5 48 33 38.20 29.01 31.68%
2021-07-24 5 48 33 38.20 29.80 28.19%
2021-07-17 4 48 33 39.00 28.87 35.09%
2021-07-10 4 48 33 39.00 30.10 29.57%
2021-07-03 4 48 33 39.00 30.86 26.38%
2021-06-26 4 48 33 39.00 30.19 29.18%
2021-06-13 4 48 33 39.00 29.65 31.53%

OGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.57 2 2 3 0 0 7

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for OGN as an investment opportunity.

  • The upside potential (average analyst target price relative to current price) of OGN is greater than 16.64% of Pharmaceutical Products stocks.
  • The average analyst price target of OGN is higher than 73.71% of Pharmaceutical Products stocks.
  • OGN has a greater number of analysts covering the stock than 30.27% of stocks in the mid market cap category.
  • The variance in analysts' estimates of OGN is less than 63.92% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, PBH, RVMD and RUBY are the three stocks most similar to Organon & Co regarding the price target and analyst recommendation information presented here.

Is OGN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.9369 seconds.